(Q54288190)

27 May 2018

title

Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development. (English)

1 reference

27 May 2018

1 reference

Rahul Bhagat

1

1 reference

27 May 2018

Shilpa Chadaga

2

1 reference

27 May 2018

C S Premalata

3

1 reference

27 May 2018

G Ramesh

4

1 reference

27 May 2018

C Ramesh

5

1 reference

27 May 2018

V R Pallavi

6

1 reference

27 May 2018

Lakshmi Krishnamoorthy

7

1 reference

27 May 2018

publication date

10 October 2012

1 reference

27 May 2018

published in

Cellular Oncology

1 reference

27 May 2018

volume

35

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

473-479

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s13402-012-0106-4

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

21 January 2018

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Prognostic DNA methylation biomarkers in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Cytosine methylation and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Promoter hypermethylation profile of ovarian epithelial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Tumor Cell-SpecificBRCA1andRASSF1AHypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Methylation of the tumor suppressor gene RASSF1A in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

RASSF1A and the Taxol Response in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Apoptosis and APC in colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Genetic pathways in colorectal and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

APC mutations occur early during colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Borderline ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0106-4

Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients

21 January 2018

1 reference

12 December 2020

Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential)

1 reference

12 December 2020

Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer

1 reference

12 December 2020

[Methylation of selected tumor-supressor genes in benign and malignant ovarian tumors]

1 reference

12 December 2020

Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.

1 reference

12 December 2020

The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase

1 reference

12 December 2020

Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis

1 reference

12 December 2020

Methylation of serum DNA is an independent prognostic marker in colorectal cancer

1 reference

12 December 2020

10.1007/S13402-012-0106-4

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018